Procter & Gamble CO 10-Q quarterly reports

Procter & Gamble reports a 7% increase in quarterly net sales to $21.2 billion, driven by volume growth and pricing, despite ongoing restructuring costs.

Procter & Gamble reports a 1% net sales increase to $22.2 billion for Q2 FY26, with diluted EPS down 5% due to significant restructuring charges.

Procter & Gamble reported a 20% increase in net earnings to $4.8 billion for the first quarter, alongside a new $1.5-$2.0 billion restructuring plan and a $5 billion share repurchase program.

Procter & Gamble's Q3 2025 results reveal a slight dip in net sales offset by earnings growth driven by prior-year impairment charges, while the company navigates currency fluctuations and restructuring efforts.

Procter & Gamble's second quarter results show a mix of growth and challenges, with a 2% increase in net sales but a significant impact from restructuring and currency fluctuations.

Procter & Gamble's first quarter results show a slight decrease in net sales and a significant drop in net earnings due to restructuring charges, despite some positive growth in specific segments.

Procter & Gamble's Q3 2024 results show a slight increase in net sales but are impacted by a significant non-cash impairment charge related to the Gillette brand.

Procter & Gamble's second quarter results for fiscal year 2024 show a net sales increase but are impacted by a significant non-cash impairment charge related to the Gillette brand.